News
note researchers in ‘The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia’, a comment published in the March 2025 issue of The Lancet Regional ...
Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in assessing complex cardiac arrhythmias such as atrial ...
The trial – sponsored by the University of Liverpool – will collect data from acute ... atrial fibrillation research, and would help inform clinical practice and improve our care and ...
Discover why difficult breathing might indicate heart disease, lung conditions, anxiety disorders, or blood problems, and ...
Sportschosun on MSN15d
Double the mortality rate of general cerebral infarction, cerebral infarction, and improve survival rate when taking beta-blockersA research team led by Professor Bae Hee-joon of the Department of Neurology at Seoul National University Bundang Hospital (Professor Lee Kun-joo of Department of Neurology at Korea University ...
7d
Zacks Investment Research on MSNBiotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & MoreIt was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession ...
A large-scale study led by researchers at the University of Pennsylvania has found that children and adolescents who ...
South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage biotechnology company advancing best-in-class ...
Several management strategies have been used with no clear consensus ... p=0.03), diabetic, and without atrial fibrillation. Subjects with tandem occlusions were more likely to have intracranial ...
Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China Background: Serum uric acid (SUA) and lipid metabolism disorders are closely associated with atrial ...
It is planned to enrol 296 subjects with non-valvular atrial fibrillation (NVAF ... of LAAC worldwide and new breakthroughs in device development, the antithrombotic management strategy of NVAF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results